BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24452698)

  • 21. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.
    Chang L; Gong F; Cui Y
    Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between NOB1 expression and prognosis of resected non-small cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    Int J Biol Markers; 2015 Feb; 30(1):e43-8. PubMed ID: 25450647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOB1 in non-small-cell lung cancer: expression profile and clinical significance.
    Liu K; Gu MM; Chen HL; You QS
    Pathol Oncol Res; 2014 Apr; 20(2):461-6. PubMed ID: 24272676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens.
    Wu YY; Wu HC; Wu JE; Huang KY; Yang SC; Chen SX; Tsao CJ; Hsu KF; Chen YL; Hong TM
    J Exp Clin Cancer Res; 2019 Jul; 38(1):282. PubMed ID: 31262325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-326 functions as a tumor suppressor in glioma by targeting the Nin one binding protein (NOB1).
    Zhou J; Xu T; Yan Y; Qin R; Wang H; Zhang X; Huang Y; Wang Y; Lu Y; Fu D; Chen J
    PLoS One; 2013; 8(7):e68469. PubMed ID: 23869222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of toll-like receptor 4 inhibits human NSCLC cancer cell growth and inflammatory cytokine secretion in vitro and in vivo.
    Li D; Jin Y; Sun Y; Lei J; Liu C
    Int J Oncol; 2014 Aug; 45(2):813-21. PubMed ID: 24889928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NOB1 expression predicts early response to cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    J Chemother; 2016 Jun; 28(3):225-9. PubMed ID: 25971309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein.
    Wu L; Hui H; Wang LJ; Wang H; Liu QF; Han SX
    Oncol Rep; 2015 May; 33(5):2309-18. PubMed ID: 25760058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer.
    Li T; Lu J; Zhong Y
    J BUON; 2013; 18(4):908-14. PubMed ID: 24344016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of NOB1 inhibits proliferation and promotes apoptosis in human oral squamous cell carcinoma.
    Yin J; Wang J; Jiang Y; Wang L; Wu H; Liu H
    Oncol Rep; 2015 Dec; 34(6):3077-87. PubMed ID: 26370469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
    Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
    Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin.
    Suwei D; Liang Z; Zhimin L; Ruilei L; Yingying Z; Zhen L; Chunlei G; Zhangchao L; Yuanbo X; Jinyan Y; Gaofeng L; Xin S
    J Hematol Oncol; 2015 Oct; 8():120. PubMed ID: 26503334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
    Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
    Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. By downregulating Ku80, hsa-miR-526b suppresses non-small cell lung cancer.
    Zhang ZY; Fu SL; Xu SQ; Zhou X; Liu XS; Xu YJ; Zhao JP; Wei S
    Oncotarget; 2015 Jan; 6(3):1462-77. PubMed ID: 25596743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced PDCD4 Expression Promotes Cell Growth Through PI3K/Akt Signaling in Non-Small Cell Lung Cancer.
    Zhen Y; Li D; Li W; Yao W; Wu A; Huang J; Gu H; Huang Y; Wang Y; Wu J; Chen M; Wu D; Lyu Q; Fang W; Wu B
    Oncol Res; 2016 Jan; 23(1-2):61-8. PubMed ID: 26802652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. piR-651 promotes tumor formation in non-small cell lung carcinoma through the upregulation of cyclin D1 and CDK4.
    Li D; Luo Y; Gao Y; Yang Y; Wang Y; Xu Y; Tan S; Zhang Y; Duan J; Yang Y
    Int J Mol Med; 2016 Sep; 38(3):927-36. PubMed ID: 27431575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of ZIC5 promotes proliferation in non-small cell lung cancer.
    Sun Q; Shi R; Wang X; Li D; Wu H; Ren B
    Biochem Biophys Res Commun; 2016 Oct; 479(3):502-509. PubMed ID: 27663664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.